Document Type
Article
Publication Date
9-1-2017
Abstract
Clinical Pharmacology & Therapeutics (CPT) is an established voice of the discipline, a trusted source of new knowledge showcasing discovery, translation, and application of novel therapeutic paradigms to advance the management of patients and populations. Identifying, evaluating, prioritizing, and disseminating the best science along the discovery-development-regulatory-utilization continuum are responsibilities shared through peer review. To enhance the uniformity of this essential component of quality assurance and innovation, and maximize the value of the journal and its contents to authors, reviewers, and the readership, we review key concepts concerning peer review as it specifically relates to CPT.
Recommended Citation
Waldman, Scott A. and Terzic, Andre M., "Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics." (2017). Department of Pharmacology and Experimental Therapeutics Faculty Papers. Paper 85.
https://jdc.jefferson.edu/petfp/85
PubMed ID
28782825
Comments
This article has been peer reviewed. It is the authors' final version prior to publication in Clinical Pharmacology and Therapeutics
Volume 102, Issue 3, September 2017, Pages 373-377.
The published version is available at DOI: 10.1002/cpt.763. Copyright © ASCPT